4.93
Schlusskurs vom Vortag:
$4.99
Offen:
$4.62
24-Stunden-Volumen:
23,473
Relative Volume:
0.01
Marktkapitalisierung:
$7.36M
Einnahmen:
$8.62M
Nettoeinkommen (Verlust:
$-6.15M
KGV:
-0.447
EPS:
-11.03
Netto-Cashflow:
$-5.32M
1W Leistung:
-13.51%
1M Leistung:
-17.97%
6M Leistung:
-8.70%
1J Leistung:
-14.11%
Evoke Pharma Inc Stock (EVOK) Company Profile
Firmenname
Evoke Pharma Inc
Sektor
Telefon
858-345-1494
Adresse
420 STEVENS AVENUE, SOLANA BEACH, CA
Vergleichen Sie EVOK mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EVOK
Evoke Pharma Inc
|
4.93 | 8.17M | 8.62M | -6.15M | -5.32M | -11.03 |
![]()
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.61B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.98B | 958.27M | 5.31B | 0.2964 |
![]()
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-06-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2019-03-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2018-03-08 | Bestätigt | B. Riley FBR, Inc. | Buy |
2017-10-19 | Fortgesetzt | FBR & Co. | Buy |
2017-03-16 | Bestätigt | Rodman & Renshaw | Buy |
2017-01-30 | Hochstufung | Laidlaw | Neutral → Buy |
2017-01-05 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
2016-12-23 | Bestätigt | Rodman & Renshaw | Neutral |
2016-07-19 | Bestätigt | FBR Capital | Outperform |
2016-07-19 | Herabstufung | Noble Financial | Buy → Hold |
2016-07-18 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
2016-03-16 | Eingeleitet | Northland Capital | Outperform |
2016-03-14 | Bestätigt | Ascendiant Capital Markets | Buy |
2016-02-17 | Fortgesetzt | FBR Capital | Outperform |
2014-12-03 | Bestätigt | MLV & Co | Buy |
2014-11-07 | Eingeleitet | MLV & Co | Buy |
2014-04-22 | Eingeleitet | Laidlaw | Buy |
2013-11-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
What machine learning models say about Evoke Pharma Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - Newser
Will Volume Confirm Reversal in Evoke Pharma Inc.July 2025 Market Mood & Fast Gain Stock Trading Tips - 선데이타임즈
Using data filters to optimize entry into Evoke Pharma Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Evoke Pharma Inc. stock trendline breakdown2025 Volatility Report & Smart Money Movement Alerts - Newser
Why Evoke Pharma Inc. stock attracts strong analyst attentionWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Is Evoke Pharma Inc. trending in predictive chart modelsConsistent Profit Signals with AI Models - Newser
Using RSI to spot recovery in Evoke Pharma Inc.Consistent Return Setup with Exit Strategy - Newser
How sentiment analysis helps forecast Evoke Pharma Inc.Buy Strategy Review With Performance Summary - Newser
Can a trend reversal in Evoke Pharma Inc. lead to recoveryFree Real Market Momentum Signal Generator - Newser
Tools to monitor Evoke Pharma Inc. recovery probabilityIntelligent Trade Forecast With AI Analytics - Newser
Published on: 2025-08-11 01:03:10 - Newser
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025Earnings Based Stock Performance Forecast - Newser
Top Risks to Consider Before Buying Evoke Pharma Inc. StockGrowth Summary Based on Market Positioning - Newser
Evoke Pharma (EVOK) to Release Quarterly Earnings on Tuesday - Defense World
Will Evoke Pharma Inc. stock go up in YEARFastest Growing Stocks to Watch - thegnnews.com
Real time scanner hits for Evoke Pharma Inc. explainedHigh Probability Trade Outcome Prediction - Newser
Evoke Pharma Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Reviewing Sol-Gel Technologies (NASDAQ:SLGL) and Evoke Pharma (NASDAQ:EVOK) - Defense World
Evoke Pharma's GIMOTI Patent Extended to 2038 Through New Patent Issuance - AInvest
Evoke Pharma's GIMOTI Patent Extended To 2038 Following New Patent Issuance - Nasdaq
Evoke Pharma announces issuance of new U.S. patent for GIMOTI - TipRanks
Evoke Pharma Secures New U.S. Patent for GIMOTI® - TipRanks
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI Wi - GuruFocus
Evoke Pharma's Extended Market Exclusivity for GIMOTI: A Strategic IP and Regulatory Triumph for Long-Term Growth - AInvest
Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038 - TradingView
Evoke Pharma, Inc. Announces New U.S. Patent for GIMOTI® with Extended Market Exclusivity to November 2038 - Quiver Quantitative
Evoke Pharma extends GIMOTI patent protection until 2038 - Investing.com
Evoke Pharma extends GIMOTI patent protection until 2038 By Investing.com - Investing.com Canada
GIMOTI Gastroparesis Treatment Secures 2-Year Patent Extension, Strengthening Market Position Through 2038 - Stock Titan
Applying chart zones and confluence areas to Evoke Pharma Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Evoke Pharma Inc. stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsSecure Buy Strategy Based on Risk Parameters - Newser
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
How does Evoke Pharma Inc. compare to its industry peersBuild a diversified portfolio for stability - Jammu Links News
What analysts say about Evoke Pharma Inc. stockHigh-octane gains - Jammu Links News
Is it the right time to buy Evoke Pharma Inc. stockMaximize your investment portfolio’s performance - Jammu Links News
When is Evoke Pharma Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News
Can momentum traders help lift Evoke Pharma Inc.Technical Confirmation System with Signal Alerts - Newser
How does Evoke Pharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - Jammu Links News
How volatile is Evoke Pharma Inc. stock compared to the marketOutperformance with explosive growth - Jammu Links News
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):